Press Releases

…

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Cookie	Type	Duration	Description
__stid	0	1 year	The cookie is set by ShareThis. The cookie is used for site analytics to determine the pages visited, the amount of time spent, etc.
__stidv	0	1 year	The cookie is set by ShareThis. The cookie is used for site analytics to determine the pages visited, the amount of time spent, etc.
_ga	0	2 years	This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, camapign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assigns a randoly generated number to identify unique visitors.
_gat	0	1 minute	This cookies is installed by Google Universal Analytics to throttle the request rate to limit the colllection of data on high traffic sites.
_gid	0	1 day	This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the wbsite is doing. The data collected including the number visitors, the source where they have come from, and the pages viisted in an anonymous form.
_hrmts_locationString	1		Unclassified 3rd party cookie used by the HR Manager service
cookielawinfo-checkbox-necessary	0	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-non-necessary	0	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Non Necessary".
fpestid	0	1 year	Fpestid is a ShareThis cookie ID set in the domain of the website operator.
locale	session	1 month	Used by the site to show content to users based on their selected location.
test_cookie	0	11 months
viewed_cookie_policy	0	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

News & Events

Press Releases

Trinity Biotech Announces Q3 2024 Financial Results

Trinity Biotech Regains Compliance with Nasdaq Listing Requirements

Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture

Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform

Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market

Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer

Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology

Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial Officer

Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales

Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing Director

Trinity Biotech Announces Q2 2024 Financial Results

Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements

Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScience

Trinity Biotech Announces Appointment of A New CFO

Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes Association

Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance

Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI

Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development

Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates

Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change

News & Events

Press Releases

Choose Location